Johnson & Johnson Vision Presents Data at #Academy23 that Demonstrates Eye Care Professionals and Patients Prefer ACUVUE® MAX 1-Day Contact Lenses
- New data highlights ECPs & Patients agree that ACUVUE® OASYS MAX 1-Day provides Unprecedented Comfort†
- Inaugural Empowering Diversity in Optometry workshop to address how optometry community can advance eyecare access
- #VisionMadePossible booth activation encourages attendees to support Sight for Kids®
JACKSONVILLE, FL, October 10, 2023 – Johnson & Johnson Vision*, a global leader in eye health and part of Johnson & Johnson MedTech**, will present data on the ACUVUE® OASYS MAX 1-Day Brand Family of lenses and research on myopia progression, along with learning opportunities and support of Sight for Kids® at the Academy 2023 New Orleans meeting, October 11 – 14. Studies being presented showed that 90% of eye care professionals agreed that ACUVUE® OASYS MAX 1-Day contact lenses provide unprecedented levels of comfort† and 99% agreed that ACUVUE® OASYS MAX 1-Day MULTIFOCAL contact lenses provided patients all-day comfort.†
“We are driven by the opportunity that exists to make vision possible for patients at every stage of life,” said Lori Tierney, President of Americas, Johnson & Johnson Vision.‡ “At the American Academy of Optometry annual meeting we’re putting a spotlight on our industry-leading innovations that help pediatric and adult patients see better, while also shining a spotlight on the importance of prioritizing diveristy in the optometry community and enabling access to eye care for all.”
And in celebration of World Sight Day on October 12th and the launch of the company’s new Vision Made Possible campaign, a donation will be made to Sight For Kids® on behalf of attendees who visit the company’s booth (#1219), take a photo, and share it using #VisionMadePossible.
Showcasing Clinical Data on ACUVUE® OASYS MAX 1-Day and Research on Myopia Progression
A Large-Scale in Practice Evaluation of a Novel Daily Disposable Spherical Contact Lens
Kurt Moody, OD; Thursday, October 12, 4:30 p.m. – 6:30 p.m. CT; Poster #102, Exhibit Hall D
An in-practice survey was conducted among 81 eye care professionals to evaluate the clinical performance of more than 1,200 patients that were fitted with ACUVUE® OASYS MAX 1-Day contact lenses. Findings showed that 90% of eye care professionals agreed that ACUVUE® OASYS MAX 1-Day contact lenses provide unprecedented levels of comfort,† 96% agreed that these lenses deliver on the needs of patients with intense digital device usage† and 91% also agreed that these lenses are their first choice for upgrading patients.†
A Large-Scale in Practice Evaluation of a Novel Daily Disposable Multifocal Contact Lens
Ed Wygonik, OD; October 12, 4:30 p.m. – 6:30 p.m. CT; Poster #101, Exhibit Hall D
The in-practice survey among 81 eye care professionals also examined the clinical performance of ACUVUE® OASYS MAX 1-Day MULTIFOCAL contact lenses and included more than 870 patients that were fitted with these lenses. The findings showed 95% of eye care professionals agreed that MAX MULTIFOCAL lenses meet the needs of their presbyopic patients† and 99% agreed it provided patients all-day comfort.† Among the 390 patient surveys received, 3 out of 4 agreed that these lenses provided clear vision in all lighting conditions.†
Can we really distinguish ‘non-responders’ to myopia control interventions?
Alex Nixon, OD; Wednesday, October 11, 8:30 a.m. – 10:00 a.m. CT; Room 356 – 357
A sub-analysis of the Low-concentration Atropine for Myopia Progression (LAMP) study, a robustly designed, placebo- controlled trial with children aged 4 to 12 years, was conducted to calculate the efficacy for each intervention by subject age and overall myopia progression. The results showed that, within each intervention group, faster progressors achieved a similar absolute reduction in axial elongation and myopia progression as the slower progressors, and that use of the terms ‘responders’ and ‘non-responders’ is inappropriate.
Elevating Importance of DE&I and Community Through the Empowering Diversity in Optometry Workshop
As a champion for advancing diverse communities in eye care, Johnson & Johnson Vision will be bringing its Empowering Diversity in Optometry series for the first time at Academy 2023 New Orleans, with the theme “The Heart of a Place,” to embrace the unique and diverse culture in New Orleans. This two-hour workshop will discuss the importance of coming together to serve as a catalyst for change through advancing access to eye care and increasing diverse representation of optometrists. Attendees will be reflecting on their experiences, sharing stories with their peers, and learning from panelists and each other about the importance of contributing to the communities they serve.
*About Johnson & Johnson Vision
At Johnson & Johnson Vision, part of Johnson & Johnson MedTech**, we have a bold ambition: to change the trajectory of eye health around the world. Through our operating companies, we deliver innovation that enables eye care professionals to create better outcomes for patients throughout their lives, with products and technologies that address unmet needs including refractive error, cataracts and dry eye. In communities with greatest need, we work in collaboration to expand access to quality eye care, and we are committed to helping people see better, connect better and live better. Visit us at www.jjvision.com. Follow @JNJVision on Twitter and Johnson & Johnson Vision on LinkedIn, and @JNJVision on Facebook.
**About Johnson & Johnson MedTech
At Johnson & Johnson MedTech, we unleash diverse healthcare expertise, purposeful technology, and a passion for people to transform the future of medical intervention and empower everyone to live their best life possible. For more than a century, we have driven breakthrough scientific innovation to address unmet needs and reimagine health. In surgery, orthopedics, vision, and interventional solutions, we continue to help save lives and create a future where healthcare solutions are smarter, less invasive, and more personalized.
About Sight for Kids®
Sight For Kids®, co-founded by Johnson & Johnson Vision Lions Clubs International Foundation (LCIF), is the largest- known, school-based eye health program in the world, having served more than 48 million children in Asia, Africa, and the U.S., since the program’s inception in 2002. In 2022, the program was expanded to the greater New Orleans area through a partnership event with the Louisiana Lions Eye Foundation and InspireNOLA Charter Schools.
Important Safety Information:
ACUVUE® Brand Contact Lenses are indicated for vision correction. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. Consult the package insert for complete information. Complete information is also available from Johnson & Johnson Vision Care, Inc. by calling 1-800-843-2020, or by visiting JNJVISIONPRO.com.
† JJV Data from the ACUVUE® OASYS MAX 1-Day In-Practice Assessment, with 81 participating Optometrists and 605 spherical and 390 multifocal patients in the US from July to October 2022
‡ Lori Tierney is an employee of Johnson & Johnson Vision with oversight as President of Americas.
PP2023AVOM4701
